Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vedat Yildiz
Observed name:
Vedat O. Yildiz
Institution:
The Ohio State University Wexner Medical Center
Observed institutions:
Nationwide Children's Hospital,
The Ohio State University Wexner Medical Center,
ORCID,
The Ohio State University
ORCID:
0000-0002-3069-7502
Observed ORCID:
0000-0002-3069-7502
OpenAlex ID:
A5106334995
Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial
2025
·
Chunjie Li
, Anne M. Noonan
, et al.
·
Clinical Cancer Research
·
9
PDF
Immunotherapy in Initial Treatment of Anaplastic Thyroid Cancer: Evaluation of Overall Survival in a National Cancer Database Study
2025
·
Shikha Kini
, Vedat Yildiz
, et al.
·
Thyroid
·
4
Intervention Fidelity in a Virtual Community Participatory Research Trial
2024
·
Holly J. Jones
, Tamilyn Bakas
, et al.
·
Nursing Research
·
2
PDF
Supplementary Tables 1 from Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial
2025
·
Chunjie Li
, Anne M. Noonan
, et al.
Supplementary Figure 1 from Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial
2025
·
Chunjie Li
, Anne M. Noonan
, et al.
Data from Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial
2025
·
Chunjie Li
, Anne M. Noonan
, et al.
supplementary materials 1 from Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial
2025
·
Chunjie Li
, Anne M. Noonan
, et al.
Show more works
View as search
Works count:
7
Citation count:
15
H-index:
2
I10-index:
Year
Topic
Type